NHS National Framework Tenofovir alafenamide/Emtricitabine 200/10mg & 200/25mg

contractFind a Tender ↗Ref ocds-h6vhtk-0668beProcurement Act 2023SME suitableplanned

Estimated value

£59.6m

goods

Awarded value

—

Suppliers

Lots

0 awarded

Published

28 May 2026

This is a preliminary market engagement notice

Map the supplier landscape and document your shortlist before opening the tender. The market simulation produces a defensible audit record you can attach to your procurement file.

Run market simulation

Description

Project title: NHS National Framework Tenofovir alafenamide/Emtricitabine 200/10mg & 200/25mg Offer reference number: CM/TNS/26/5744 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/26/5744 Tenofovir alafenamide/Emtricitabine 200/10mg & 200/25mg Lot 1 LNW 1 February 2027 to 31 October 2028 (21 months) Lot 2 DNE & SOFE 1 February 2027 to 31 October 2028 (21 months) Lot 2 DNW & MAE 1 February 2027 to 31 October 2028 (21 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Scope

Reference: CM/TNS/26/5744
Total value: £59,625,000 excluding VAT
£71,550,000 including VAT
Above the relevant threshold
Commercial tool: Standalone contract
Contract dates: 01 Feb 2027 to 31 Oct 2028
Possible extension to 31 Oct 2030
Main category: goods
CPV classifications: 33600000
Contract locations: North East England, United Kingdom
North West England, United Kingdom
East Midlands, United Kingdom
West Midlands, United Kingdom
East of England, United Kingdom
South East England, United Kingdom
South West England, United Kingdom
Particular suitability: Small and medium-sized enterprises (SME)